The rising prevalence in GLP-1 agonists for diabetes has led to a debate about formats: transdermal systems versus tablets . Usually , GLP-1 treatments were exclusively available in oral form, but the https://fanniezwab242541.mdkblog.com/47105908/glp-1-transdermal-delivery-systems-vs-tablets-what-right-for-you